New research from the Centres for Antimicrobial Optimisation Network (CAMO-Net) at the University of Liverpool has shown that using artificial intelligence (AI) can improve how we treat urinary tract infections (UTIs), and help to address antimicrobial resistance (AMR).
CureVac releases mixed interim Phase 2 data for seasonal flu vaccine
CureVac’s seasonal flu vaccine boosted antibody titers in influenza A strains but it missed the mark in influenza B in a Phase 2 trial. The